IRadimed Corporation
IRMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3.9% | 4.6% | 0.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 77.8% | 78.2% | 76.1% | 76.1% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 36.2% | 38.8% | 28.8% | 33.7% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 26.3% | 28.3% | 24% | 26.5% |
| EPS Diluted | 0.434 | 0.45 | 0.37 | 0.4 |
| % Growth | -3.6% | 21.6% | -7.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |